|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.8 TWD | +1.27% |
|
+1.82% | -25.10% |
GeneFerm Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 793.77 million compared to TWD 633.96 million a year ago. Net income was TWD 124.62 million compared to TWD 93.45 million a year ago.
Basic earnings per share from continuing operations was TWD 3.01 compared to TWD 2.26 a year ago. Diluted earnings per share from continuing operations was TWD 2.99 compared to TWD 2.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.10% | 70.92M | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
GENEFERM BIOTECHNOLOGY CO., LTD. 
